Cardionomic is a medical diagnostics and research company that develops and commercializes non-invasive diagnostic tests for cardiovascular diseases. The company's flagship product is the Cardionomic Heart Failure Diagnostic Test, which is designed to help physicians diagnose heart failure in patients with shortness of breath. The test measures the level of a biomarker called NT-proBNP, which is released into the bloodstream when the heart is under stress. Cardionomic's mission is to improve patient outcomes and reduce healthcare costs by providing accurate and reliable diagnostic tests that enable early detection and treatment of cardiovascular diseases.